New Research Explains Why Immunotherapy Is Less Effective in Children With Cancer
- OPACC
- Jan 31
- 1 min read
"Children’s immune systems respond to cancer immunotherapy differently from adults, according to a study from Karolinska Institutet. The researchers found that tumors in children with cancer often evade immune detection, suggesting why many existing immunotherapies fail in children. These findings could advance pediatric cancer treatment and introduce precision medicine tailored to the unique immune landscapes of young patients."
Recent Posts
See AllWhile the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...
Untreated growth hormone deficiency was associated with neurocognitive impairment and reduced physical functioning among adult survivors...
Comments